APA (7th ed.) Citation

Y, M., TN, G., NG, M., D, V., A, B., P, C., . . . JS, W. (2026). Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma. NPJ precision oncology, 10(1), 55. https://doi.org/10.1038/s41698-025-01230-y

Chicago Style (17th ed.) Citation

Y, Mao, et al. "Prospective Tumour Mutation Burden and Neoantigen Profiling Predicts Immunotherapy Response in Metastatic Melanoma." NPJ Precision Oncology 10, no. 1 (2026): 55. https://doi.org/10.1038/s41698-025-01230-y.

MLA (9th ed.) Citation

Y, Mao, et al. "Prospective Tumour Mutation Burden and Neoantigen Profiling Predicts Immunotherapy Response in Metastatic Melanoma." NPJ Precision Oncology, vol. 10, no. 1, 2026, p. 55, https://doi.org/10.1038/s41698-025-01230-y.